DexCom EBITDA Margin 2012-2025 | DXCM
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for DexCom (DXCM) over the last 10 years. The current EBITDA margin for DexCom as of September 30, 2025 is .
| DexCom EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-09-30 | $4.52B | $1.02B | 22.65% |
| 2025-06-30 | $4.30B | $0.92B | 21.48% |
| 2025-03-31 | $4.15B | $0.86B | 20.68% |
| 2024-12-31 | $4.03B | $0.82B | 20.28% |
| 2024-09-30 | $3.95B | $0.84B | 21.24% |
| 2024-06-30 | $3.94B | $0.89B | 22.54% |
| 2024-03-31 | $3.80B | $0.85B | 22.33% |
| 2023-12-31 | $3.62B | $0.78B | 21.64% |
| 2023-09-30 | $3.40B | $0.68B | 19.89% |
| 2023-06-30 | $3.20B | $0.61B | 19.07% |
| 2023-03-31 | $3.02B | $0.56B | 18.49% |
| 2022-12-31 | $2.91B | $0.55B | 18.83% |
| 2022-09-30 | $2.79B | $0.42B | 15.00% |
| 2022-06-30 | $2.67B | $0.38B | 14.07% |
| 2022-03-31 | $2.57B | $0.38B | 14.77% |
| 2021-12-31 | $2.45B | $0.37B | 15.07% |
| 2021-09-30 | $2.32B | $0.46B | 19.84% |
| 2021-06-30 | $2.17B | $0.43B | 19.77% |
| 2021-03-31 | $2.03B | $0.39B | 19.09% |
| 2020-12-31 | $1.93B | $0.37B | 19.05% |
| 2020-09-30 | $1.82B | $0.36B | 19.71% |
| 2020-06-30 | $1.72B | $0.32B | 18.36% |
| 2020-03-31 | $1.60B | $0.24B | 15.19% |
| 2019-12-31 | $1.48B | $0.19B | 12.94% |
| 2019-09-30 | $1.35B | $-0.08B | -6.00% |
| 2019-06-30 | $1.22B | $-0.13B | -10.47% |
| 2019-03-31 | $1.13B | $-0.14B | -12.13% |
| 2018-12-31 | $1.03B | $-0.16B | -15.21% |
| 2018-09-30 | $0.92B | $0.02B | 1.64% |
| 2018-06-30 | $0.83B | $0.00B | -0.36% |
| 2018-03-31 | $0.76B | $-0.02B | -1.97% |
| 2017-12-31 | $0.72B | $-0.03B | -3.76% |
| 2017-09-30 | $0.67B | $-0.05B | -6.88% |
| 2017-06-30 | $0.63B | $-0.06B | -10.11% |
| 2017-03-31 | $0.60B | $-0.07B | -11.69% |
| 2016-12-31 | $0.57B | $-0.05B | -8.55% |
| 2016-09-30 | $0.53B | $-0.04B | -7.88% |
| 2016-06-30 | $0.49B | $-0.07B | -13.91% |
| 2016-03-31 | $0.45B | $-0.05B | -11.91% |
| 2015-12-31 | $0.40B | $-0.05B | -11.69% |
| 2015-09-30 | $0.36B | $-0.05B | -13.24% |
| 2015-06-30 | $0.32B | $-0.01B | -3.13% |
| 2015-03-31 | $0.29B | $-0.01B | -4.56% |
| 2014-12-31 | $0.26B | $-0.01B | -5.02% |
| 2014-09-30 | $0.23B | $-0.02B | -7.49% |
| 2014-06-30 | $0.20B | $-0.02B | -8.96% |
| 2014-03-31 | $0.18B | $-0.02B | -12.36% |
| 2013-12-31 | $0.16B | $-0.02B | -13.04% |
| 2013-09-30 | $0.14B | $-0.03B | -19.01% |
| 2013-06-30 | $0.12B | $-0.04B | -31.15% |
| 2013-03-31 | $0.11B | $-0.04B | -39.45% |
| 2012-12-31 | $0.10B | $-0.05B | -48.48% |
| 2012-09-30 | $0.09B | $-0.05B | -60.23% |
| 2012-06-30 | $0.08B | $-0.05B | -60.24% |
| 2012-03-31 | $0.08B | $-0.04B | -53.09% |
| 2011-12-31 | $0.08B | $-0.04B | -53.33% |
| 2011-09-30 | $0.07B | $-0.04B | -55.07% |
| 2011-06-30 | $0.06B | $-0.04B | -60.32% |
| 2011-03-31 | $0.05B | $-0.04B | -77.78% |
| 2010-12-31 | $0.05B | $-0.04B | -82.00% |
| 2010-09-30 | $0.04B | $-0.04B | -93.18% |
| 2010-06-30 | $0.04B | $-0.04B | -102.56% |
| 2010-03-31 | $0.03B | $-0.04B | -123.53% |
| 2009-12-31 | $0.03B | $-0.04B | -144.83% |
| 2009-09-30 | $0.02B | $-0.05B | -195.65% |
| 2009-06-30 | $0.02B | $-0.05B | -261.11% |
| 2009-03-31 | $0.01B | $-0.05B | -369.23% |
| 2008-12-31 | $0.01B | $-0.05B | -500.00% |
| 2008-09-30 | $0.01B | $-0.05B | -625.00% |
| 2008-06-30 | $0.01B | $-0.05B | -685.71% |
| 2008-03-31 | $0.01B | $-0.05B | -766.67% |
| 2007-12-31 | $0.01B | $-0.05B | -900.00% |
| 2007-09-30 | $0.00B | $-0.04B | -1100.00% |
| 2007-06-30 | $0.00B | $-0.05B | -1175.00% |
| 2007-03-31 | $0.00B | $-0.05B | -1566.67% |
| 2006-12-31 | $0.00B | $-0.05B | -2350.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $26.948B | $4.662B |
| DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $189.665B | 22.07 |
| Intuitive Surgical (ISRG) | United States | $172.536B | 66.55 |
| IDEXX Laboratories (IDXX) | United States | $50.254B | 48.15 |
| Edwards Lifesciences (EW) | United States | $44.027B | 29.64 |
| Alcon (ALC) | Switzerland | $39.174B | 26.40 |
| IQVIA Holdings (IQV) | United States | $28.430B | 15.36 |
| Mettler-Toledo (MTD) | United States | $27.662B | 31.81 |
| STERIS (STE) | Ireland | $24.357B | 24.64 |
| Waters (WAT) | United States | $19.256B | 24.63 |
| Coloplast (CLPBY) | Denmark | $17.511B | 26.79 |
| Hologic (HOLX) | United States | $16.752B | 17.53 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.334B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.168B | 11.75 |
| Penumbra (PEN) | United States | $13.288B | 93.47 |
| Globus Medical (GMED) | United States | $11.790B | 24.74 |
| SARTORIUS (SSSGY) | Germany | $7.976B | 46.32 |
| Masimo (MASI) | United States | $6.991B | 22.40 |
| Glaukos (GKOS) | United States | $6.287B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $5.363B | 17.75 |
| Teleflex (TFX) | United States | $4.585B | 7.31 |
| TransMedics (TMDX) | United States | $4.437B | 52.57 |
| LivaNova (LIVN) | United Kingdom | $3.593B | 19.41 |
| Integer Holdings (ITGR) | United States | $3.011B | 14.13 |
| Veracyte (VCYT) | United States | $2.828B | 32.22 |
| Elekta AB (EKTAY) | Sweden | $2.266B | 21.19 |
| Alphatec Holdings (ATEC) | United States | $1.985B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $1.975B | 21.79 |
| UFP Technologies (UFPT) | United States | $1.896B | 25.03 |
| Artivion (AORT) | United States | $1.734B | 58.10 |
| Pulse Biosciences (PLSE) | United States | $1.559B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $1.553B | 0.00 |
| AxoGen (AXGN) | United States | $1.533B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.285B | 0.00 |
| IRadimed (IRMD) | United States | $1.270B | 57.03 |
| OPKO Health (OPK) | United States | $0.944B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.882B | 4.78 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.692B | 13.80 |
| SiBone (SIBN) | United States | $0.665B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.614B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.612B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.591B | 34.35 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.530B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.516B | 0.00 |
| NeuroPace (NPCE) | United States | $0.501B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.500B | 13.03 |
| AngioDynamics (ANGO) | United States | $0.452B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.424B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.385B | 0.00 |
| RxSight (RXST) | United States | $0.331B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.329B | 54.76 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Sight Sciences (SGHT) | United States | $0.283B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.281B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.235B | 0.00 |
| 908 Devices (MASS) | United States | $0.235B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.183B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.175B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.173B | 0.00 |
| Inogen (INGN) | United States | $0.156B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.149B | 0.00 |
| LENSAR (LNSR) | United States | $0.146B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.146B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.132B | 0.00 |
| CVRx (CVRX) | United States | $0.130B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.119B | 0.00 |
| Hyperfine (HYPR) | United States | $0.108B | 0.00 |
| Neuronetics (STIM) | United States | $0.097B | 0.00 |
| Solana (HSDT) | United States | $0.091B | 0.00 |
| DarioHealth (DRIO) | United States | $0.079B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| InspireMD (NSPR) | United States | $0.074B | 0.00 |
| Positron (POSC) | United States | $0.067B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.067B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.063B | 0.00 |
| Accuray (ARAY) | United States | $0.062B | 0.00 |
| Spectral AI (MDAI) | United States | $0.048B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.036B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.026B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.021B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.020B | 0.00 | |
| Envoy Medical (COCH) | United States | $0.017B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.013B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| NexGel (NXGL) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.006B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ENvue Medical (FEED) | United States | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |